Alpha DNA Investment Management’s Parker-Hannifin PH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,099
Closed -$1.21M 212
2023
Q2
$1.21M Sell
3,099
-1,125
-27% -$381K 0.4% 39
2023
Q1
$1.42M Sell
4,224
-217
-5% -$71.9K 0.42% 43
2022
Q4
$1.29M Buy
+4,441
New +$1.27M 0.46% 55
2021
Q3
Sell
-5,901
Closed -$1.81M 137
2021
Q2
$1.81M Buy
5,901
+2,967
+101% +$918K 1.24% 12
2021
Q1
$925K Sell
2,934
-513
-15% -$148K 1.06% 12
2020
Q4
$938K Buy
+3,447
New +$854K 1% 26

Other funds holding PH

Alpha DNA Investment Management's PH Position: Q3 2023 in Review

Alpha DNA Investment Management sold out of Parker-Hannifin (PH) in Q3 2023, closing a stake of 3,099 shares — an estimated $1.21M sold.

Alpha DNA Investment Management first reported a position in PH in Q4 2020 and held it in 6 quarters. The position peaked at $1.81M in Q2 2021. 1,178 funds tracked by Wall St. Rank hold PH as of Q3 2023.

  • Alpha DNA Investment Management reported no remaining Parker-Hannifin position as of Q3 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3,099 Parker-Hannifin shares in Q3 2023, an estimated $1.21M.
  • Alpha DNA Investment Management first reported a position in Parker-Hannifin in Q4 2020 and held it in 6 quarters.
  • Alpha DNA Investment Management's Parker-Hannifin position peaked at $1.81M in Q2 2021.
  • 1,178 funds tracked by Wall St. Rank held Parker-Hannifin as of Q3 2023.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.